Ethan Lovell | Chief of External Affairs & Communications Officer |
Garo Armen | Chairman & Chief Executive Officer |
Christine Klaskin | Vice President-Finance |
Steven O'Day | Chief Medical Officer |
Dhan Chand | Scientific Director, Head of Drug Discovery |
Mayank Mamtani | B. Riley Securities |
Matt Phipps | William Blair |
Good morning. My name is Abby and I will be your conference operator today. At this time, I would like to welcome everyone to the Agenus Second Quarter 2022 Financial Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session.